Directors_NNS statements_NNS of_IN responsibility_NN Directors_NNS statement_NN of_IN responsibility_NN in_IN relation_NN to_TO Internal_NNP control_NN the_DT consolidated_JJ financial_JJ statements_NNS The_DT Board_NNP ,_, through_IN the_DT Audit_NNP Committee_NNP ,_, has_VBZ reviewed_VBN the_DT The_DT Directors_NNS are_VBP responsible_JJ for_IN :_: assessment_NN of_IN risks_NNS and_CC the_DT internal_JJ control_NN framework_NN that_WDT operates_VBZ in_IN GlaxoSmithKline_NNP and_CC has_VBZ considered_VBN the_DT effectiveness_NN of_IN the_DT system_NN ensuring_VBG the_DT maintenance_NN of_IN proper_JJ accounting_NN records_NNS ,_, which_WDT of_IN internal_JJ control_NN in_IN operation_NN in_IN the_DT Group_NNP for_IN the_DT year_NN covered_VBN by_IN disclose_VB with_IN reasonable_JJ accuracy_NN the_DT financial_JJ position_NN of_IN the_DT Group_NNP this_DT report_NN and_CC up_RB to_TO the_DT date_NN of_IN its_PRP$ approval_NN by_IN the_DT Board_NNP of_IN Directors_NNS ._.
at_IN any_DT time_NN and_CC from_IN which_WDT financial_JJ statements_NNS can_MD be_VB prepared_VBN to_TO comply_VB with_IN the_DT Companies_NNS Act_NNP 1985_CD and_CC Article_NNP 4_CD of_IN the_DT IAS_NNP The_NNP Combined_NNP Code_NNP Regulation_NNP The_NNP Board_NNP considers_VBZ that_IN GlaxoSmithKline_NNP plc_NN applies_VBZ the_DT principles_NNS of_IN preparing_VBG financial_JJ statements_NNS for_IN each_DT financial_JJ period_NN which_WDT give_VBP the_DT Combined_NNP Code_NNP on_IN Corporate_NNP Governance_NNP of_IN the_DT Financial_NNP a_DT true_JJ and_CC fair_JJ view_NN ,_, in_IN accordance_NN with_IN IFRS_NNP as_IN adopted_VBN for_IN use_NN in_IN Reporting_NNP Council_NNP ,_, as_IN described_VBN under_IN Corporate_JJ governance_NN on_IN the_DT European_NNP Union_NNP ,_, of_IN the_DT state_NN of_IN affairs_NNS of_IN the_DT Group_NNP as_IN at_IN the_DT pages_NNS 27_CD to_TO 36_CD ,_, and_CC has_VBZ complied_VBN with_IN its_PRP$ provisions_NNS except_IN as_IN end_NN of_IN the_DT financial_JJ period_NN and_CC of_IN the_DT profit_NN or_CC loss_NN for_IN that_DT period_NN described_VBN on_IN pages_NNS 35_CD and_CC 36_CD ._.
ensuring_VBG the_DT operation_NN of_IN systems_NNS of_IN internal_JJ control_NN and_CC for_IN taking_VBG As_IN required_VBN by_IN the_DT Listing_NNP Rules_NNP of_IN the_DT Financial_NNP Services_NNPS Authority_NNP ,_, the_DT reasonable_JJ steps_NNS to_TO safeguard_VB the_DT assets_NNS of_IN the_DT Group_NNP and_CC for_IN auditors_NNS have_VBP considered_VBN the_DT Directors_NNS statement_NN of_IN compliance_NN in_IN preventing_VBG and_CC detecting_VBG fraud_NN and_CC other_JJ irregularities_NNS ._.
relation_NN to_TO those_DT points_NNS of_IN the_DT Combined_NNP Code_NNP which_WDT are_VBP specified_VBN The_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31st_CD December_NNP 2005_CD ,_, for_IN their_PRP$ review_NN ._.
comprising_VBG principal_JJ statements_NNS and_CC supporting_VBG notes_NNS ,_, are_VBP set_VBN out_RP in_IN Financial_NNP statements_NNS on_IN pages_NNS 84_CD to_TO 164_CD of_IN this_DT report_NN ._.
Annual_JJ Report_NNP The_DT Directors_NNS confirm_VBP that_IN suitable_JJ accounting_NN policies_NNS have_VBP been_VBN The_DT Annual_JJ Report_NNP for_IN the_DT year_NN ended_VBD 31st_CD December_NNP 2005_CD ,_, consistently_RB applied_VBN in_IN the_DT preparation_NN of_IN the_DT financial_JJ statements_NNS ,_, comprising_VBG the_DT Report_NNP of_IN the_DT Directors_NNS ,_, the_DT Remuneration_NNP Report_NNP ,_, the_DT supported_VBN by_IN reasonable_JJ and_CC prudent_JJ judgements_NNS and_CC estimates_NNS Financial_NNP statements_NNS and_CC additional_JJ information_NN for_IN investors_NNS ,_, has_VBZ as_RB necessary_JJ ._.
been_VBN approved_VBN by_IN the_DT Board_NNP of_IN Directors_NNS and_CC signed_VBN on_IN its_PRP$ behalf_NN by_IN The_DT responsibilities_NNS of_IN the_DT auditors_NNS in_IN relation_NN to_TO the_DT financial_JJ statements_NNS are_VBP set_VBN out_RP in_IN the_DT Independent_NNP Auditors_NNS report_VBP page_NN 83_CD opposite_NN ._.
The_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31st_CD December_NNP 2005_CD are_VBP included_VBN in_IN the_DT Annual_JJ Report_NNP 2005_CD ,_, which_WDT is_VBZ published_VBN in_IN hard-copy_JJ printed_VBN form_NN and_CC made_VBN available_JJ on_IN the_DT website_NN ._.
The_DT Directors_NNS are_VBP Sir_NNP Christopher_NNP Gent_NNP responsible_JJ for_IN the_DT maintenance_NN and_CC integrity_NN of_IN the_DT Annual_JJ Report_NNP Chairman_NNP on_IN the_DT website_NN in_IN accordance_NN with_IN UK_NNP legislation_NN governing_VBG the_DT 1st_CD March_NNP 2006_CD preparation_NN and_CC dissemination_NN of_IN financial_JJ statements_NNS ._.
Access_NN to_TO the_DT website_NN is_VBZ available_JJ from_IN outside_IN the_DT UK_NNP ,_, where_WRB comparable_JJ legislation_NN may_MD be_VB different_JJ ._.
Directors_NNS remuneration_VBP The_DT Remuneration_NNP Report_NNP on_IN pages_NNS 37_CD to_TO 54_CD sets_NNS out_IN the_DT remuneration_NN policies_NNS operated_VBN by_IN GlaxoSmithKline_NNP and_CC disclosures_NNS on_IN Directors_NNS remuneration_NN and_CC other_JJ disclosable_JJ information_NN relating_VBG to_TO Directors_NNS and_CC officers_NNS and_CC their_PRP$ interests_NNS ._.
It_PRP has_VBZ been_VBN prepared_VBN in_IN accordance_NN with_IN the_DT Companies_NNS Act_NNP 1985_CD and_CC complies_VBZ with_IN Section_NN B_NN of_IN the_DT Combined_NNP Code_NNP on_IN Corporate_NNP Governance_NNP ._.
Going_VBG concern_NN basis_NN After_IN making_VBG enquiries_NNS ,_, the_DT Directors_NNS have_VBP a_DT reasonable_JJ expectation_NN that_IN the_DT Group_NNP has_VBZ adequate_JJ resources_NNS to_TO continue_VB in_IN operational_JJ existence_NN for_IN the_DT foreseeable_JJ future_NN ._.
For_IN this_DT reason_NN ,_, they_PRP continue_VBP to_TO adopt_VB the_DT going_VBG concern_NN basis_NN in_IN preparing_VBG the_DT financial_JJ statements_NNS ._.
GSK_NNP Annual_JJ Report_NNP 2005_CD 82_CD FINANCIAL_NNP STATEMENTS_NNS
